Tafinlar 00078-1154-21

Generic: Dabrafenib

Package NDC

00078-1154-21

Manufacturer: Novartis Pharmaceuticals Corporation
Dosage Form: Tablet, For Suspension
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: March 16, 2023
Listing Expires: December 31, 2027
Application: NDA217514

Need to source Tafinlar? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Dabrafenib Mesylate	10 mg/1

Drug Class

Breast Cancer Resistance Protein Inhibitors [MoA]Cytochrome P450 2B6 Inducers [MoA]Cytochrome P450 2C19 Inducers [MoA]

Selected Package

00078-1154-21Selected

210 TABLET, FOR SUSPENSION in 1 BOTTLE (0078-1154-21)